NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile

Title
NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile
Authors
Keywords
-
Journal
MEDICAL MYCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-02-29
DOI
10.1093/mmy/myaa015

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started